Monday, December 9, 2024

CATEGORY

ALK-Abello

ALK Publishes Promising Phase 3 Results for Children’s Allergy Treatment in Esteemed Journal

A recent publication in The Lancet Regional Health Europe showcases ALK's groundbreaking Phase 3 trial, MT-12, which evaluates the effectiveness and safety of their...

Latest news